Todd Hore

14/11/2022

Bowel Cancer New Zealand is extremely disappointed to learn that in the recent announcement of new medicines being funded by PHARMAC, none are for bowel cancer.

Bowel cancer has not had a new drug funded for over 20 years, this is simply not acceptable for the second deadliest cancer in Aotearoa.

In 2019, PHARMAC’s Cancer Treatment Subcommittee recommended that cetuximab be funded as a first-line treatment for metastatic bowel cancer, as a “significant benefit was seen” when this class of medicine was added to chemotherapy. Cetuximab was funded in Australia in 2011, but still not here in New Zealand.

It’s also been more than 10 years since bevacizumab (Avastin) was added to the Medicine Waiting List. The average time on the wait list for medicines to be funded is almost 5 years and growing. In Australia, bevacizumab was funded in 2009.

Twice as many modern medicines are funded in Australia as they are in New Zealand, and the United Kingdom funds more than three and a half times as many.

The full list of the seven new drugs to be funded, plus the widening access of 2 other drugs can be viewed here: http://bit.ly/3UW4WWn

We are pleased for those sufferers that will benefit from these new drugs, and we know the need is great - however, we must continue to fight for our bowel cancer community to get funded access to the medicines they so desperately need.

29/01/2022

Had my booster last week and I encourage everyone to do the same. If we minimise the impact of Covid we can keep operating.

03/12/2021

Ka pai Cantabrians! 🎉👏🏆

We’ve hit the 90% fully vaccinated mark. Thanks, and congratulations to everyone who has been vaccinated. Every vaccination counts especially as we head into the festive season. 🎄🎅

A massive thank you to all our vaccination teams for their mahi and to everyone helping behind the scenes to help us reach this goal.

More info 👉 https://www.cdhb.health.nz/media-release/canterbury-reaches-90-percent-fully-vaccinated-milestone/

26/10/2021

We are not asking the public to be expert immunologists, we are just asking them to trust us. We know what we're doing.

08/10/2021

Please vaccinate so we can keep doing our job to help those who desperately need surgery.

HOME News, media releases & advocacy One in seven patients miss cancer surgery during COVID lockdowns - study One in seven patients miss cancer surgery during COVID lockdowns - study One in seven cancer patients around the world have missed out on poten...

14/07/2021

Fantastic news.

Previously, patients with the cancer had to travel to Melbourne to access the treatment, but it will now be available in Auckland.

Previously, patients with the cancer had to travel to Melbourne to access the treatment, but it will now be available in Auckland.

14/07/2021

Well done Niue!

The island country is among the first in the world to reach herd immunity and held a national celebration to mark the milestone.

The island country is among the first in the world to reach herd immunity and held a national celebration to mark the milestone.

27/06/2021

Part of a great team in Christchurch who can match it with the best :)

Retrospective study analysing Textbook Outcomes (TO) following pancreatic surgery performed at Christchurch Hospital, NZ and comparing these outcomes to those from the Netherlands nationwide analysis...

20/03/2021

I am happy to provide another portal for patients looking for a General Surgeon or Hepatopancreatobiliary Surgeon in Christchurch, New Zealand